Skip to main content

Table 2 Content of interviews and types, and numbers of interviewees

From: Bridging the gap between basic science and clinical practice: a role for community clinicians

Early phase one interviewsa

Later phase two interviewsb

Type of intervieweec

Number of interviews

(total = 243)

Incentives and disincentives for provider participation, including organizational barriers and motivators

Best practices in community research networks, and how new provider networks might partner with these

Community clinicians (Individual primary care clinicians, dentists, nurse practitioners) and clinician organizations (health plans, large community practices) not currently participating in research

37

Strategies for provider participation and retention

Proposed provider effort as complementary to or in competition with existing clinician organizations; Liability and marketing concerns

Individual clinicians and health provider organizations already participating in clinical research

30

Ethical and professional issues

Optimal design for studies in community practices; Costs associated with conducting various types of clinical research studies in community settings

Leaders and coordinators of clinical research networks (e.g., CCOPs, AMC leaders, PBRNs)

80

Advantages and limitations of different types of research networks/organizations by study and provider type and the potential role of emerging information systems

Governance, oversight, and quality control for NCRA

Representatives of private-sector organizations (e.g., CROs) and stakeholders (e.g., professional associations, pharmaceutical companies) with relevant experience and interest

77

Specific recommendations to NIH on design of physician recruitment and incentives

Addressing privacy, HIPAA and institutional review boards issues

Representatives of public and government entities (e.g., leaders from NIH institutes and other federal agencies) with relevant experience and interest

19

  1. a A list of key issues discussed during early phases of interviews. See Appendix 1 for list of early phase interview informants.
  2. b A list of key issues discussed during later interviews, after review of transcripts of early interviews. See Appendix 2 for list of later phase interview informants.
  3. c Interviewees were selected from a listing developed by key stakeholders, authors of pertinent publications, recommendations by national organizations, and by recommendations by NIH Institute Leaders. Contact with members of this list, supplemented by snowball sampling, was used to generate the list of interviewees table.